Characterization of Post-Operative Hemodynamics Following the Norwood Procedure Using Population Data and Multi-Scale

Jonathan Primeaux1, Arash Salavitabar2, Jimmy C Lu2

  • 1Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI, United States.

Insights

Hypoplastic left heart syndrome (HLHS) requires staged surgeries. This study used computational fluid dynamics to analyze blood flow immediately after the Norwood procedure, revealing disturbed hemodynamics critical for post-operative success.

Area of Science:

  • Pediatric Cardiology
  • Biomedical Engineering
  • Congenital Heart Disease Research

Background:

  • Hypoplastic left heart syndrome (HLHS) necessitates staged surgical palliation.
  • The Norwood procedure (Stage I) establishes initial single-ventricle circulation.
  • Hemodynamic data immediately post-Stage I is scarce but vital for assessing surgical outcomes.

Purpose of the Study:

  • To characterize hemodynamics in HLHS patients immediately following Stage I palliation and prior to Stage II.
  • To utilize computational fluid dynamics (CFD) combined with population data to model these critical early stages.

Main Methods:

  • Developed patient-specific computational fluid dynamics (CFD) models.
  • Scaled models using population-based morphological and hemodynamic data for post-Stage I and pre-Stage II time-points.
  • Calibrated models to accurately represent HLHS patient blood flow.

Main Results:

  • Post-Stage I simulation showed elevated pulmonary artery (PA) pressure (22 mmHg) and disturbed flow.
  • Pre-Stage II model indicated reduced PA mean pressure (14 mmHg) but persistent high-frequency flow components.
  • Increased PA wall shear stress was observed in the pre-Stage II model.

Conclusions:

  • HLHS patients exhibit suboptimal hemodynamics immediately post-Stage I and pre-Stage II.
  • These conditions may be compensatory to maintain adequate PA flow as the shunt size becomes relatively smaller.
  • CFD holds potential for optimizing shunt design to mitigate adverse hemodynamic conditions.